`
`
`Trials@uspto.gov
`571-272-7822
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner,
`
`v.
`
`GENENTECH, INC.,
`Patent Owner.
`____________
`
`Case IPR2016-01693
`Patent 6,407,213
`____________
`
`Mailed: September 16, 2016
`
`Before Alexander C. Levy, Trial Paralegal
`
`NOTICE OF FILING DATE ACCORDED TO PETITION
`AND
`TIME FOR FILING PATENT OWNER PRELIMINARY RESPONSE
`
`The petition for “inter partes review” in the above proceeding has
`been accorded the filing date of August 30, 2016.
`
`
`
`IPR2016-01693
`Patent 6,407,213
`
`
`A review of the petition identified the following defects:
`Petitioner failed to include a certification stating the number of words
`in the petition. See 37 C.F.R. § 42.24(d). Correction is required.
`Petitioner incorrectly labelled the exhibit number on exhibit 1117.
`See 37 C.F.R. § 42.63(c). Correction is required. Petitioner may submit a
`written request to trials@uspto.gov to have the incorrectly labelled exhibit
`expunged specifically identifying the exhibit to be expunged (e.g., by the
`name given to the exhibit in the Patent Trial and Appeal Board End to End
`(PTAB E2E) and/or by the date the exhibit was filed).
`Petitioner must correct these defects within FIVE BUSINESS DAYS
`from this notice. Failure to correct the defects may result in an order to
`show cause as to why the Board should institute the trial. No substantive
`changes (e.g., new grounds) may be made to the petition.
`Patent Owner may file a preliminary response to the petition no later
`than three months from the date of this notice. The preliminary response is
`limited to setting forth the reasons why the requested review should not be
`instituted. Patent Owner may also file an election to waive the preliminary
`response to expedite the proceeding. For more information, please consult
`the Office Patent Trial Practice Guide, 77 Fed. Reg. 48756 (Aug. 14, 2012),
`which is available on the Board Web site at http://www.uspto.gov/PTAB.
`Patent Owner is advised of the requirement to submit mandatory
`notice information under 37 C.F.R. § 42.8(a)(2) within 21 days of service of
`the petition.
`The parties are encouraged to use the heading on the first page of this
`Notice for all future filings in the proceeding.
`
`
`
`2
`
`
`
`IPR2016-01693
`Patent 6,407,213
`
`
`The parties are advised that under 37 C.F.R. § 42.10(c), recognition of
`counsel pro hac vice requires a showing of good cause. The parties are
`authorized to file motions for pro hac vice admission under 37 C.F.R.
`§ 42.10(c). Such motions shall be filed in accordance with the “Order --
`Authorizing Motion for Pro Hac Vice Admission” in Case IPR2013-00639,
`Paper 7, a copy of which is available on the Board Web site under
`“Representative Orders, Decisions, and Notices.”
`The parties are reminded that unless otherwise permitted by 37 C.F.R.
`§ 42.6(b)(2), all filings in this proceeding must be made electronically in
`Patent Trial and Appeal Board End to End (PTAB E2E), accessible from the
`Board Web site at http://www.uspto.gov/PTAB. To file documents, users
`must register with PTAB E2E. Information regarding how to register with
`and use PTAB E2E is available at the Board Web site.
`If there are any questions pertaining to this notice, please contact
`Alexander C. Levy at 571-272-0382 or the Patent Trial and Appeal Board at
`571-272-7822.
`
`3
`
`
`
`
`
`
`
`IPR2016-01693
`Patent 6,407,213
`
`PETITIONER:
`
`Jeffrey W. Guise
`Wilson Sonsini Goodrich & Rosati
`
`Deanne M. Mazzochi
`Rakoczy Molino Mazzochi Siwik LLP
`
`jguise@wsgr.com
`dmazzochi@rmmslegal.com
`
`PATENT OWNER:
`
`GENENTECH, INC.
`1 DNA Way
`South San Francisco, CA 94080-4990
`
`GENENTECH, INC.
`460 Point San Bruno Blvd.
`So. San Francisco, CA 94080
`
`SIDLEY AUSTIN LLP
`2001 Ross Avenue
`Suite 3600
`Dallas, TX 75201
`
`
`
`4
`
`
`
`NOTICE CONCERNING ALTERNATIVE DISPUTE RESOLUTION
`(ADR)
`The Patent Trial and Appeal Board (PTAB) strongly encourages
`
`parties who are considering settlement to consider alternative dispute
`resolution as a means of settling the issues that may be raised in an AIA trial
`proceeding. Many AIA trials are settled prior to a Final Written Decision.
`Those considering settlement may wish to consider alternative dispute
`resolution techniques early in a proceeding to produce a quicker, mutually
`agreeable resolution of a dispute or to at least narrow the scope of matters in
`dispute. Alternative dispute resolution has the potential to save parties time
`and money.
`
`Many non-profit organizations, both inside and outside the intellectual
`property field, offer alternative dispute resolution services. Listed below are
`the names and addresses of several such organizations. The listings are
`provided for the convenience of parties involved in cases before the PTAB;
`the PTAB does not sponsor or endorse any particular organization’s
`alternative dispute resolution services. In addition, consideration may be
`given to utilizing independent alternative dispute resolution firms. Such
`firms may be located through a standard keyword Internet search.
`
`
`CPR
`INSTITUTE
`FOR DISPUTE
`RESOLUTION
`
`IPR2016-01693
`Patent 6,407,213
`
`
`AMERICAN
`INTELLECTUAL
`PROPERTY
`LAW
`ASSOCIATION
`(AIPLA)
`Telephone:
`(703) 415-0780
`Fax: (703) 415-0786
`241 18th Street, South,
`Suite 700
`Arlington, VA 22202
`
`Telephone:
`(212) 949-6490
`Fax: (212) 949-8859
`
`575 Lexington Ave
`New York, NY 10022
`
`AMERICAN
`ARBITRATIO
`N
`ASSOCIATIO
`N (AAA)
`
`Telephone:
`(212) 484-3266
`Fax: (212) 307-4387
`140 West 51st
`Street
`New York, NY
`10020
`www.adr.org
`
`WORLD
`INTELLECTUA
`L PROPERTY
`ORGANIZATI
`ON (WIPO)
`Telephone:
`41 22 338 9111
`Fax: 41 22 733 5428
`34, chemin des
`Colombettes
`CH-1211 Geneva 20,
`Switzerland
`www.wipo.int
`
`AMERICAN
`BAR
`ASSOCIATION
`(ABA)
`
`Telephone :
`(202) 662-1000
`N/A
`1050 Connecticut Ave,
`NW
`Washington D.C. 20036
`
`www.americanbar.org
`
`www.cpradr.org
`
`www.aipla.org
`
`
`
`If parties to an AIA trial proceeding consider using alternative dispute
`resolution, the PTAB would like to know whether the parties ultimately
`decided to engage in alternative dispute resolution and the reasons why or
`why not. If the parties actually engage in alternative dispute resolution, the
`PTAB would be interested to learn what mechanism (e.g., arbitration,
`
`
`
`5
`
`
`
`IPR2016-01693
`Patent 6,407,213
`
`mediation, etc.) was used and the general result. Such a statement from the
`parties is not required but would be helpful to the PTAB in assessing the
`value of alternative dispute resolution to parties involved in AIA trial
`proceedings. To report an experience with ADR, please forward a summary
`of
`the
`particulars
`to
`the
`following
`address:
`PTAB_ADR_Comments@uspto.gov
`
`
`
`
`
`6
`
`